Abnormalities of Serum Lipid, Lipoprotein and Apolipoprotein in Both Normotriglyceridemic and Hypertriglyceridemic Patients with Chronic Renal Failure on Chronic Hemodialysis.
- Author:
Kyu Sung CHO
1
;
Gyeong Ran CHOI
;
Seung Jung KEE
;
Soo Hyun KIM
;
Myung Geun SHIN
;
Jong Hee SHIN
;
Soon Pal SUH
;
Dong Wook RYANG
Author Information
1. Department of Clinical Pathology, Chonnam University Medical School
- Publication Type:Original Article
- Keywords:
Hypertriglyceridemia;
Chronic renal failure;
Lipid;
Lipoprotein;
Apolipoprotein
- MeSH:
Apolipoprotein A-I;
Apolipoprotein C-III;
Apolipoproteins B;
Apolipoproteins E;
Apolipoproteins*;
Atherosclerosis;
Cardiovascular Diseases;
Cholesterol;
Dyslipidemias;
Humans;
Hypertriglyceridemia;
Incidence;
Kidney Failure, Chronic*;
Lipoproteins*;
Plasma;
Renal Dialysis*;
Triglycerides
- From:Korean Journal of Clinical Pathology
1999;19(4):414-419
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Hypertriglyceridemia (HTG) has been considered a characteristic plasma lipid abnormality in hemodialysis patients with chronic renal failure, but is actually shown in only some of them (30-50%). Also renal dyslipidemia may contribute to atherosclerosis in hemodialysis patients. METHODS: Study population consisted of 34 patients with normotriglyceridemia (NTG), 11 patients with HTG and 47 controls. We measured total cholesterol (TC), triglyceride (TG), high density lipoprotein-cholesterol (HDL-C), apolipoprotein (apo) A-I, apoB, apoC-III and apoE. RESULTS: Compared with controls, the NTG patients had significantly decreased levels of TC, HDL-C, and low density lipoprotein-cholesterol (LDL-C). But HTG patients had significantly increased TG, and TC/HDL-C ratio which were considered to represent the atherogenic indicator and had decreased HDL-C and LDL-C (P <0.001), with significant increase of TG and TC/HDL-C ratio compared with those of NTG patients. In the apolipoprotein profiles, all patients showed decreased levels of apoA-I, apoB, and apoA-I/apoC-III ratio and increased levels of apoC-III and apoC-III/apoE ratio compared with those of controls (P <0.001). Especially, HTG patients had significantly increased levels of apoC-III compared with NTG patients. CONCLUSIONS: So these results indicated that abnormalities of those potentially atherogenic lipid and lipoproteins may contribute to the high incidence of cardiovascular diseases and progression of renal disease in the HTG patients than NTG patients on maintenance hemodialysis.
